UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 148

Sortiert nach

Peripheral and intrahepatic virological phenotyping in eAg negative chronic hepatitis B to evaluate risk of disease progression and hepatocellular carcinoma in the “grey-zone” viral load cohort

Journal of hepatology, 2017, Vol.66 (1), p.S701-S701

2017

Link zum Volltext

Verfügbarkeit prüfen

K444 Clinical implications of viral evolution and variability

International journal of antimicrobial agents, 2007, Vol.29, p.S93-S94

Perno, C.F

2007

Link zum Volltext

Verfügbarkeit prüfen

An outbreak of acute hepatitis C GT1b in onco-hematological patients. Treatment with Sofosbuvir + Ledipasvir and concomitant chemotherapy

Journal of hepatology, 2017, Vol.66 (1), p.S502-S503

2017

Link zum Volltext

Verfügbarkeit prüfen

Peripheral and intrahepatic virological phenotyping in HBeAg negative Chronic Hepatitis B to evaluate risk of disease progression and HCC in the “grey-zone” viral load cohort: Can grey-zone patients be candidate to treatment?

Digestive and liver disease, 2017-02, Vol.49 (1), p.e7-e7

2017

Link zum Volltext

Verfügbarkeit prüfen

Molecular analysis based on mtLSU-rRNA and DHPS sequences of Pneumocystis jirovecii from immunocompromised and immunocompetent patients in Italy

Infection, genetics and evolution, 2013-03, Vol.14, p.68-72

2013

Link zum Volltext

Verfügbarkeit prüfen

A High Density of Mutations within HLA Class I and II HBsAg/RT Epitopes Characterizes HBV Variants Emerging during Immune-Suppression Driven HBV Reactivation

Journal of hepatology, 2016, Vol.64 (2), p.S376-S377

2016

Link zum Volltext

Verfügbarkeit prüfen

Different Prevalence of HCV Resistance and HCV RNA Quantification Within Tumoral and Non Tumoral Liver Tissues in HCC/Transplanted Patients

Journal of hepatology, 2016, Vol.64 (2), p.S416-S417

2016

Link zum Volltext

Verfügbarkeit prüfen

Failure to First-Line Direct Antiviral (DAA) Treatment of HCV Infection in an Italian Real-Life Urban Setting

Journal of hepatology, 2016, Vol.64 (2), p.S755-S755

2016

Link zum Volltext

Verfügbarkeit prüfen

P0912 : Early-phase HCV kinetics and role of pre-existing resistance in cirrhotic or interferon-insensitive patients on daclatasvir plus asunaprevir

Journal of hepatology, 2015-04, Vol.62, p.S686-S687

2015

Link zum Volltext

Verfügbarkeit prüfen

Gain of positively charged amino acids at specific positions of HBsAg C-terminus tightly correlates with HBV-induced hepatocellular carcinoma by altering the structural folding of this domain

Journal of hepatology, 2017, Vol.66 (1), p.S684-S684

2017

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis Delta Antigen (HDAg) is characterized by an extensive degree of genetic variability that correlates with elevated levels of serum HDV-RNA

Journal of hepatology, 2017, Vol.66 (1), p.S250-S251

2017

Link zum Volltext

Verfügbarkeit prüfen

The circulation of specific vaccine-escape HBsAg mutations in HBV genotype D infected patients correlates with high viremia and affects HBsAg detection and quantification

Journal of hepatology, 2017, Vol.66 (1), p.S681-S681

2017

Link zum Volltext

Verfügbarkeit prüfen

34 WEANING OF HBV PROPHYLAXIS AFTER LIVER TRANSPLANTATION: PRELIMINARY RESULTS IN PATIENTS WITH UNDETECTABLE CCCDNA IN LIVER TISSUE

Journal of hepatology, 2009, Vol.50, p.S15-S15

2009

Link zum Volltext

Verfügbarkeit prüfen

Interim analysis of study of kinetics of CMV-DNA load in whole blood and plasma samples of allogeneic hematopoietic stem cell transplant (HSCT) recipients

Journal of clinical virology, 2015-09, Vol.70, p.S80-S81

2015

Link zum Volltext

Verfügbarkeit prüfen

Virological Failures to New Direct Acting Antivirals in a Real Life Setting May Require Unconventional Regimens for Re-Treatment

Journal of hepatology, 2016, Vol.64 (2), p.S410-S410

2016

Link zum Volltext

Verfügbarkeit prüfen

Daclatasvir/sofosbuvir and ribavirin 800 mg flat dose is highly efficacy and safe in genotype 3 compensated and decompensated cirrhotic patients: The CLEO experience

Digestive and liver disease, 2017-02, Vol.49 (1), p.e64-e64

2017

Link zum Volltext

Verfügbarkeit prüfen

Carbohydrate-binding agents (CBAs) inhibit HIV-1 infection in human primary monocyte-derived macrophages (MDMs) and efficiently prevent MDM-directed viral capture and subsequent transmission to CD4+ T lymphocytes

Virology (New York, N.Y.), 2008-01, Vol.370 (2), p.382-391

2008

Link zum Volltext

Verfügbarkeit prüfen

Resource Use and Disease Progression Among HCV-Positive Patients

Value in health, 2013-11, Vol.16 (7), p.A494-A494

2013

Link zum Volltext

Verfügbarkeit prüfen

P0580 : Genetic signatures specifically clustered in immune active HBsAg regions correlate with immunosuppression-driven HBV reactivation: An extensive analysis of HBV genome

Journal of hepatology, 2015-04, Vol.62, p.S533-S533

2015

Link zum Volltext

Verfügbarkeit prüfen

P0625 : A hyper-glycosylation of HBV surface major hydrophilic region characterizes HBV reactivation driven by immunosuppression and affects HBsAg recognition in vitro

Journal of hepatology, 2015-04, Vol.62, p.S553-S553

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 148

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(148)
Mit Volltextzugriff
(146)

Publikationsform

Artikel
(148)

Sprache

Englisch
(148)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Peripheral and intrahepatic virological phenotyping in eAg negative chronic hepatitis B to evaluate risk of disease progression and hepatocellular carcinoma in the “grey-zone” viral load cohort

K444 Clinical implications of viral evolution and variability

An outbreak of acute hepatitis C GT1b in onco-hematological patients. Treatment with Sofosbuvir + Ledipasvir and concomitant chemotherapy

Peripheral and intrahepatic virological phenotyping in HBeAg negative Chronic Hepatitis B to evaluate risk of disease progression and HCC in the “grey-zone” viral load cohort: Can grey-zone patients be candidate to treatment?

Molecular analysis based on mtLSU-rRNA and DHPS sequences of Pneumocystis jirovecii from immunocompromised and immunocompetent patients in Italy

A High Density of Mutations within HLA Class I and II HBsAg/RT Epitopes Characterizes HBV Variants Emerging during Immune-Suppression Driven HBV Reactivation

Different Prevalence of HCV Resistance and HCV RNA Quantification Within Tumoral and Non Tumoral Liver Tissues in HCC/Transplanted Patients

Failure to First-Line Direct Antiviral (DAA) Treatment of HCV Infection in an Italian Real-Life Urban Setting

P0912 : Early-phase HCV kinetics and role of pre-existing resistance in cirrhotic or interferon-insensitive patients on daclatasvir plus asunaprevir

Gain of positively charged amino acids at specific positions of HBsAg C-terminus tightly correlates with HBV-induced hepatocellular carcinoma by altering the structural folding of this domain

In HBeAg-negative chronic HBV infection, HBsAg levels profoundly vary among different HBV-genotypes and can be influenced by the degree of HBsAg variability: can quantitative HBsAg truly reflect intra-hepatic HBV reservoir?

Hepatitis Delta Antigen (HDAg) is characterized by an extensive degree of genetic variability that correlates with elevated levels of serum HDV-RNA

The circulation of specific vaccine-escape HBsAg mutations in HBV genotype D infected patients correlates with high viremia and affects HBsAg detection and quantification

34 WEANING OF HBV PROPHYLAXIS AFTER LIVER TRANSPLANTATION: PRELIMINARY RESULTS IN PATIENTS WITH UNDETECTABLE CCCDNA IN LIVER TISSUE

Vaccine-Escape HBsAg Mutations Circulating in a Relevant Proportion of HBV Genotype D Infected Patients Correlate with Atypical Serological Profiles, High Viremia and Transaminases: Potential Implication for Vaccine Success

Biphasic Kinetics of HCV-RNA Decay is Accompanied by an even Faster Aminotransferases Normalization in All-Daa Treated Cirrhotic Patients: A Different Scenario from Interferon-Based Therapies

Interim analysis of study of kinetics of CMV-DNA load in whole blood and plasma samples of allogeneic hematopoietic stem cell transplant (HSCT) recipients

Virological Failures to New Direct Acting Antivirals in a Real Life Setting May Require Unconventional Regimens for Re-Treatment

Immune-Escape Mutations and Stop-Codons in HBsAg Circulates in a Relevant Proportion of Patients with Chronic HBV Infection Exposed to Anti-HBV Drugs in Europe: Implications for HBV Transmission in the Setting of Vaccination and Disease Progression

Daclatasvir/sofosbuvir and ribavirin 800 mg flat dose is highly efficacy and safe in genotype 3 compensated and decompensated cirrhotic patients: The CLEO experience

Carbohydrate-binding agents (CBAs) inhibit HIV-1 infection in human primary monocyte-derived macrophages (MDMs) and efficiently prevent MDM-directed viral capture and subsequent transmission to CD4+ T lymphocytes

Resource Use and Disease Progression Among HCV-Positive Patients

P0580 : Genetic signatures specifically clustered in immune active HBsAg regions correlate with immunosuppression-driven HBV reactivation: An extensive analysis of HBV genome

P0625 : A hyper-glycosylation of HBV surface major hydrophilic region characterizes HBV reactivation driven by immunosuppression and affects HBsAg recognition in vitro

HCV resistance test guided retreatments after protease inhibitors failures can induce maximal efficacy rate in real-life

Suchergebnisse filtern